When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMGN - Mirati's Stock Gaps Higher On Amgen's Data Opens Up Massive Opportunity
Amgen Inc.
Mirati Therapeutics (MRTX) shares surged recently, mainly because of positive data that stemmed from Amgen (AMGN). That's because Amgen reported positive results from its Phase 1 study using its drug AMG 510. The reason why the stock of Mirati traded higher is because Amgen established proof of concept in patients for a class of a drug known as a KRAS inhibitor. Since Mirati has a similar type of drug, its stock traded higher based on Amgen's positive data.
Golden Opportunity
With Amgen reporting positive Phase 1 results from its study using